{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "D",
                    "position": "309"
                },
                "variant_string_id": "PINK1 G309D"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "PD is a progressive neurodegenerative movement disorder. The pathological hallmark is loss of dopaminergic neurons in the substantia nigra and Lewy bodies. Mitochondrial impairment is implicated in its pathogenesis, and mutations in PINK1 cause recessive hereditary PD. PINK1 is involved in phosphorylation of mitochondrial proteins and associates with chaperones. Pink1 deficiency in mice and flies leads to various phenotypes related to mitochondrial dysfunction.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines PD's pathological features and the role of mitochondrial dysfunction, as well as how PINK1 mutations are related to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses assays such as measuring Complex I activity (by spectrophotometric assays of respiratory chain complexes), synaptic function (electrophysiology and FM1 - 43 dye labelling), and mitochondrial membrane potential (using dyes like JC - 1 and TMRM). These assays model mitochondrial function and synaptic transmission, which are relevant to the PD disease mechanism defined in Step 1.",
                    "judgment": "Yes",
                    "reasoning": "The general classes of assays effectively model the disease pathogenesis related to mitochondrial and synaptic function as described in the disease mechanism in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For Complex I activity measurement, samples from different tissues of two species (mouse and fly) were used, and statistical analysis was done using Student's t - test. For synaptic function, multiple replicates were likely as indicated by the number of animals tested in electrophysiology and FM1 - 43 experiments. Basic controls like wild - type and knockout cells/tissues were used, and for synaptic function, controls included normal and mutant Drosophila neurons. Variant controls were used as human wild - type PINK1 and PINK1 - containing clinical mutations were compared in rescuing Complex I deficiency and synaptic function.",
                    "sub_step": "3a: Basic Controls and Replicates",
                    "judgment": "Yes",
                    "reasoning": "Both normal (wild - type) and abnormal (knockout or mutant) controls were used, and the use of multiple animals in experiments implies multiple replicates were done.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Known pathogenic (clinical PINK1 mutations) and non - pathogenic (wild - type PINK1) variants were used as controls in rescuing Complex I deficiency and synaptic function assays.",
                    "sub_step": "3c: Variant Controls",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic and non - pathogenic variants were used as controls, fulfilling the criteria for this step.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "sub_step": "4a: Statistical Analyses",
                    "extracted_paper_info": "Statistical analysis was performed using Student's t - test for all measurements related to Complex I activity, synaptic function, and mitochondrial membrane potential. However, no direct mention of OddsPath calculation.",
                    "judgment": "No",
                    "reasoning": "The paper does not mention calculating OddsPath, only uses Student's t - test for statistical significance.",
                    "next_step_or_outcome": "Proceed to Step 4b"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "sub_step": "4b: No OddsPath Calculation",
                    "extracted_paper_info": "The number of control variants used across the study for this variant's assay: For Complex I activity and synaptic function assays, multiple mutant and wild - type variants were used. While the exact number is not clearly stated as 10 or less or at least 11, considering the multiple comparisons between wild - type, knockout, and different mutant PINK1 variants in different assays (Complex I activity in different tissues and synaptic function), it can be inferred that there are more than 10 control variants.",
                    "judgment": "At least 11",
                    "reasoning": "Based on the multiple comparisons between different variants in various assays related to this variant, it is reasonable to infer that there are at least 11 control variants used in total.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The functional evidence for the PINK1 G309D variant is rated as PS3_moderate because the study clearly defined the disease mechanism, the assays used were applicable to the disease pathogenesis, basic controls and replicates were used, variant controls were present, and although OddsPath was not calculated, the number of control variants used across the study implies a moderate level of evidence according to the ACMG guidelines."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "W",
                    "alt": "X",
                    "position": "437"
                },
                "variant_string_id": "PINK1 W437X"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "PD is a progressive neurodegenerative movement disorder. The pathological hallmark is loss of dopaminergic neurons in the substantia nigra and Lewy bodies. Mitochondrial impairment is implicated in its pathogenesis, and mutations in PINK1 cause recessive hereditary PD. PINK1 is involved in phosphorylation of mitochondrial proteins and associates with chaperones. Pink1 deficiency in mice and flies leads to various phenotypes related to mitochondrial dysfunction.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines PD's pathological features and the role of mitochondrial dysfunction, as well as how PINK1 mutations are related to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses assays such as measuring Complex I activity (by spectrophotometric assays of respiratory chain complexes), synaptic function (electrophysiology and FM1 - 43 dye labelling), and mitochondrial membrane potential (using dyes like JC - 1 and TMRM). These assays model mitochondrial function and synaptic transmission, which are relevant to the PD disease mechanism defined in Step 1.",
                    "judgment": "Yes",
                    "reasoning": "The general classes of assays effectively model the disease pathogenesis related to mitochondrial and synaptic function as described in the disease mechanism in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For Complex I activity measurement, samples from different tissues of two species (mouse and fly) were used, and statistical analysis was done using Student's t - test. For synaptic function, multiple replicates were likely as indicated by the number of animals tested in electrophysiology and FM1 - 43 experiments. Basic controls like wild - type and knockout cells/tissues were used, and for synaptic function, controls included normal and mutant Drosophila neurons. Variant controls were used as human wild - type PINK1 and PINK1 - containing clinical mutations were compared in rescuing Complex I deficiency and synaptic function.",
                    "sub_step": "3a: Basic Controls and Replicates",
                    "judgment": "Yes",
                    "reasoning": "Both normal (wild - type) and abnormal (knockout or mutant) controls were used, and the use of multiple animals in experiments implies multiple replicates were done.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Known pathogenic (clinical PINK1 mutations) and non - pathogenic (wild - type PINK1) variants were used as controls in rescuing Complex I deficiency and synaptic function assays.",
                    "sub_step": "3c: Variant Controls",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic and non - pathogenic variants were used as controls, fulfilling the criteria for this step.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "sub_step": "4a: Statistical Analyses",
                    "extracted_paper_info": "Statistical analysis was performed using Student's t - test for all measurements related to Complex I activity, synaptic function, and mitochondrial membrane potential. However, no direct mention of OddsPath calculation.",
                    "judgment": "No",
                    "reasoning": "The paper does not mention calculating OddsPath, only uses Student's t - test for statistical significance.",
                    "next_step_or_outcome": "Proceed to Step 4b"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "sub_step": "4b: No OddsPath Calculation",
                    "extracted_paper_info": "The number of control variants used across the study for this variant's assay: For Complex I activity and synaptic function assays, multiple mutant and wild - type variants were used. While the exact number is not clearly stated as 10 or less or at least 11, considering the multiple comparisons between wild - type, knockout, and different mutant PINK1 variants in different assays (Complex I activity in different tissues and synaptic function), it can be inferred that there are more than 10 control variants.",
                    "judgment": "At least 11",
                    "reasoning": "Based on the multiple comparisons between different variants in various assays related to this variant, it is reasonable to infer that there are at least 11 control variants used in total.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The functional evidence for the PINK1 W437X variant is rated as PS3_moderate because the study clearly defined the disease mechanism, the assays used were applicable to the disease pathogenesis, basic controls and replicates were used, variant controls were present, and although OddsPath was not calculated, the number of control variants used across the study implies a moderate level of evidence according to the ACMG guidelines."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "K",
                    "alt": "A",
                    "position": "219"
                },
                "variant_string_id": "PINK1 K219A"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "PD is a progressive neurodegenerative movement disorder. The pathological hallmark is loss of dopaminergic neurons in the substantia nigra and Lewy bodies. Mitochondrial impairment is implicated in its pathogenesis, and mutations in PINK1 cause recessive hereditary PD. PINK1 is involved in phosphorylation of mitochondrial proteins and associates with chaperones. Pink1 deficiency in mice and flies leads to various phenotypes related to mitochondrial dysfunction.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines PD's pathological features and the role of mitochondrial dysfunction, as well as how PINK1 mutations are related to the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses assays such as measuring Complex I activity (by spectrophotometric assays of respiratory chain complexes), synaptic function (electrophysiology and FM1 - 43 dye labelling), and mitochondrial membrane potential (using dyes like JC - 1 and TMRM). These assays model mitochondrial function and synaptic transmission, which are relevant to the PD disease mechanism defined in Step 1.",
                    "judgment": "Yes",
                    "reasoning": "The general classes of assays effectively model the disease pathogenesis related to mitochondrial and synaptic function as described in the disease mechanism in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "For Complex I activity measurement, samples from different tissues of two species (mouse and fly) were used, and statistical analysis was done using Student's t - test. For synaptic function, multiple replicates were likely as indicated by the number of animals tested in electrophysiology and FM1 - 43 experiments. Basic controls like wild - type and knockout cells/tissues were used, and for synaptic function, controls included normal and mutant Drosophila neurons. Variant controls were used as human wild - type PINK1 and PINK1 - containing clinical mutations were compared in rescuing Complex I deficiency and synaptic function.",
                    "sub_step": "3a: Basic Controls and Replicates",
                    "judgment": "Yes",
                    "reasoning": "Both normal (wild - type) and abnormal (knockout or mutant) controls were used, and the use of multiple animals in experiments implies multiple replicates were done.",
                    "next_step_or_outcome": "Proceed to Step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "Known pathogenic (clinical PINK1 mutations) and non - pathogenic (wild - type PINK1) variants were used as controls in rescuing Complex I deficiency and synaptic function assays.",
                    "sub_step": "3c: Variant Controls",
                    "judgment": "Yes",
                    "reasoning": "Known pathogenic and non - pathogenic variants were used as controls, fulfilling the criteria for this step.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "sub_step": "4a: Statistical Analyses",
                    "extracted_paper_info": "Statistical analysis was performed using Student's t - test for all measurements related to Complex I activity, synaptic function, and mitochondrial membrane potential. However, no direct mention of OddsPath calculation.",
                    "judgment": "No",
                    "reasoning": "The paper does not mention calculating OddsPath, only uses Student's t - test for statistical significance.",
                    "next_step_or_outcome": "Proceed to Step 4b"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation",
                    "sub_step": "4b: No OddsPath Calculation",
                    "extracted_paper_info": "The number of control variants used across the study for this variant's assay: For Complex I activity and synaptic function assays, multiple mutant and wild - type variants were used. While the exact number is not clearly stated as 10 or less or at least 11, considering the multiple comparisons between wild - type, knockout, and different mutant PINK1 variants in different assays (Complex I activity in different tissues and synaptic function), it can be inferred that there are more than 10 control variants.",
                    "judgment": "At least 11",
                    "reasoning": "Based on the multiple comparisons between different variants in various assays related to this variant, it is reasonable to infer that there are at least 11 control variants used in total.",
                    "next_step_or_outcome": "Max PS3_moderate"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The functional evidence for the PINK1 K219A variant is rated as PS3_moderate because the study clearly defined the disease mechanism, the assays used were applicable to the disease pathogenesis, basic controls and replicates were used, variant controls were present, and although OddsPath was not calculated, the number of control variants used across the study implies a moderate level of evidence according to the ACMG guidelines."
        }
    ]
}